DCTH | Delcath Systems, Inc.![]() Company profile
Company profileDelcath Systems, Inc. (NASDAQ-DCTH) is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product ? HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) ? is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.. MORE About the CompanyDelcath Systems, Inc. Delcath Systems, Inc. is a publicly-traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
Address1633 Broadway Key Persons / Board of Directors
| NotesResearchInvestor pagedelcath.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: delcath.comSupport this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books![]() Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology. |